A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache

Completed · Phase 4 · Has a placebo group

Conditions studied: Migraine Headache

In brief

Study 20170703 is a phase 4, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of erenumab against placebo in participants with chronic migraine (CM) who have a history of at least 1 preventive treatment failure and are diagnosed with medication overuse headache (MOH).

Key facts

Study ID
NCT03971071
Run by
Amgen
People needed
620
Starts
2019-10-07
Expected to finish
2023-06-13
Last updated by the study team
2025-09-19

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.